Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell
-
A8250 LY 29400216 CitationTarget: PI3KSummary: Potent PI3K inhibitor
-
A8353 3-Methyladenine3 CitationTarget: PI3KSummary: Class III PI3K inhibitor
-
A8487 Nocodazole1 CitationTarget: Microtubules/TubulinsSummary: Tubulin production inhibitor,anti-neoplastic agent
-
A8628 Chloroquine diphosphate1 CitationTarget: AutophagySummary: Antimalarial drug,TLR7 TLR9 inhibitor
-
A8629 DBeQTarget: P97 ATPaseSummary: P97 ATPase inhibitor
-
A8633 Concanamycin A1 CitationTarget: Vacuolar-type ATPaseSummary: V-type (vacuolar) H+-ATPase inhibitor
-
A2571 Pepstatin A1 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: Aspartic protease inhibitor
-
A4083 Rocilinostat (ACY-1215)1 CitationTarget: Histone Deacetylases (HDACs)Summary: Selective HDAC6 inhibitor
-
A4393 Paclitaxel (Taxol)4 CitationTarget: Microtubules/TubulinsSummary: Antineoplastic agent